Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts. This segment also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. The Group and Specialty segment provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; financial protection products; and administrative services only products to individuals and employer groups. It also offers military services, such as TRICARE South Region contract. The Healthcare Services segment provides pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. The Individual Commercial segment offers individual commercial fully-insured medical health insurance benefits under the HumanaOne brand. The company also provides closed-block long-term care insurance policies. As of December 31, 2017, it had approximately 14 million members in medical benefit plans, as well as approximately 7 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Industry, Sector and Symbol
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
SymbolNYSE:HUM
CUSIP44485910
Phone502-580-1000
Debt
Debt-to-Equity Ratio0.47
Current Ratio1.55
Quick Ratio1.55
Price-To-Earnings
Trailing P/E Ratio25.62
Forward P/E Ratio21.44
P/E Growth1.55
Sales & Book Value
Annual Sales$53.77 billion
Price / Sales0.77
Cash Flow$15.3994 per share
Price / Cash19.48
Book Value$68.89 per share
Price / Book4.35
Profitability
EPS (Most Recent Fiscal Year)$11.71
Net Income$2.45 billion
Net Margins3.36%
Return on Equity16.74%
Return on Assets5.60%
Miscellaneous
Employees45,900
Outstanding Shares137,680,000
Humana (NYSE:HUM) Frequently Asked Questions
What is Humana's stock symbol?
Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."
How often does Humana pay dividends? What is the dividend yield for Humana?
Humana announced a quarterly dividend on Thursday, April 19th. Investors of record on Friday, June 29th will be given a dividend of $0.50 per share on Friday, July 27th. This represents a $2.00 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date of this dividend is Thursday, June 28th. View Humana's Dividend History.
How will Humana's stock buyback program work?
Humana declared that its Board of Directors has authorized a stock repurchase plan on Friday, December 15th 2017, which authorizes the company to buyback $3,000,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to purchase shares of its stock through open market purchases. Shares buyback plans are often an indication that the company's board of directors believes its shares are undervalued.
How were Humana's earnings last quarter?
Humana Inc (NYSE:HUM) issued its quarterly earnings results on Wednesday, May, 2nd. The insurance provider reported $3.36 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $3.21 by $0.15. The insurance provider earned $14.28 billion during the quarter, compared to analyst estimates of $14.22 billion. Humana had a return on equity of 16.74% and a net margin of 3.36%. During the same quarter in the previous year, the business posted $2.75 EPS. View Humana's Earnings History.
When is Humana's next earnings date?
What guidance has Humana issued on next quarter's earnings?
Humana updated its FY18 earnings guidance on Thursday, May, 31st. The company provided earnings per share (EPS) guidance of $13.70-14.10 for the period, compared to the Thomson Reuters consensus EPS estimate of $13.97.
What price target have analysts set for HUM?
17 brokers have issued 12 month price objectives for Humana's stock. Their predictions range from $221.00 to $340.00. On average, they anticipate Humana's stock price to reach $281.1176 in the next twelve months. View Analyst Ratings for Humana.
What are Wall Street analysts saying about Humana stock?
Here are some recent quotes from research analysts about Humana stock:
- 1. According to Zacks Investment Research, "Shares of Humana have outperformed the industry year to date. The insurer is well-poised for growth on its strong government business. Its top line has been witnessing an uptrend for the past several years. Sufficient generation of cash flow has helped the company take up many capital deployment initiatives aimed at enhancing its shareholders’ value. Humana’s sound balance sheet and a disciplined capital management remain major tailwinds. Following better-than-expected first-quarter results, the company provided a strong guidance for 2018. Also, the company has exited the individual commercial business effective Jan 1, 2018. Rising level of expenses persistently weighs on the bottom line. With respect to quarterly results, Humana’s first-quarter bottom line beat estimates on a favorable current-year medical utilization in Retail segment relative, lower tax rate and a positive impact of share buybacks." (5/31/2018)
- 2. Cantor Fitzgerald analysts commented, "This morning, Humana announced it would acquire a 40% interest in Curo Health Services, a large, privately-held hospice company." (4/23/2018)
Who are some of Humana's key competitors?
Who are Humana's key executives?
Humana's management team includes the folowing people:
- Mr. Bruce Dale Broussard, Pres, CEO & Director (Age 56)
- Mr. Brian Andrew Kane, Sr. VP & CFO (Age 45)
- Mr. Christopher Mark Todoroff, Chief Legal Officer (Age 55)
- Mr. Timothy S. Huval, Chief HR Officer (Age 52)
- Ms. Jody L. Bilney, Chief Consumer Officer (Age 57)
Has Humana been receiving favorable news coverage?
Press coverage about HUM stock has been trending somewhat positive recently, Accern Sentiment reports. Accern ranks the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Humana earned a news sentiment score of 0.07 on Accern's scale. They also assigned headlines about the insurance provider an impact score of 46.91 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next few days.
Who are Humana's major shareholders?
Humana's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (8.85%), Newport Trust Co (1.37%), Wells Fargo & Company MN (1.25%), Northern Trust Corp (1.21%), Dimensional Fund Advisors LP (1.14%) and Legal & General Group Plc (0.54%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming. View Institutional Ownership Trends for Humana.
Which major investors are selling Humana stock?
HUM stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, OppenheimerFunds Inc., American Century Companies Inc., Royal Bank of Canada, FIL Ltd, Natixis, State of New Jersey Common Pension Fund D and Wells Fargo & Company MN. Company insiders that have sold Humana company stock in the last year include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, Cynthia H Zipperle, Elizabeth D Bierbower, Heidi S Margulis, Jody L Bilney, M Todoroff Christopher, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming. View Insider Buying and Selling for Humana.
Which major investors are buying Humana stock?
HUM stock was purchased by a variety of institutional investors in the last quarter, including Old Mutual Global Investors UK Ltd., Ceredex Value Advisors LLC, Massachusetts Financial Services Co. MA, BlackRock Inc., Summit Trail Advisors LLC, Mackay Shields LLC, Prudential Financial Inc. and ING Groep NV. View Insider Buying and Selling for Humana.
How do I buy shares of Humana?
Shares of HUM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Humana's stock price today?
One share of HUM stock can currently be purchased for approximately $299.98.
How big of a company is Humana?
Humana has a market capitalization of $41.12 billion and generates $53.77 billion in revenue each year. The insurance provider earns $2.45 billion in net income (profit) each year or $11.71 on an earnings per share basis. Humana employs 45,900 workers across the globe.
How can I contact Humana?
Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider can be reached via phone at 502-580-1000.
MarketBeat Community Rating for Humana (HUM)
MarketBeat's community ratings are surveys of what our community members think about Humana and other stocks. Vote "Outperform" if you believe HUM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HUM will underperform the S&P 500 over the long term. You may vote once every thirty days.
